Autologous Peripheral Blood Mononuclear Cells in Diabetic Foot Patients With No-option Critical Limb Ischemia

NCT04255004 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Critical Limb Ischemia
Diabetic Foot

Interventions

DEVICE: Pall Celeris System, point of care device for human cell therapy

Sponsor

Ospedale San Donato